Explore every episode of the podcast The Lancet Oncology in conversation with
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) | 27 Aug 2024 | 00:13:22 | |
Dr Kanwal Raghav (Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA) discusses his Article entitled, ‘Trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a randomised, multicentre, phase 2 trial’. Tell us what you thought about this episode Continue this conversation on social! | |||
| Emmy Boerrigter on dose selection of novel anticancer drugs | 29 Jul 2024 | 00:11:41 | |
Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses. Tell us what you thought about this episode Continue this conversation on social! | |||
| Neerja Bhatla on a new quadrivalent HPV vaccine | 29 Nov 2023 | 00:12:24 | |
Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India. Tell us what you thought about this episode Continue this conversation on social! | |||
| Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery | 01 Nov 2023 | 00:43:49 | |
Dr Chandra Are (University of Nebraska Medical Center, Omaha, NE, USA) discusses highlights and recommendations from the Lancet Oncology Commission on Global cancer surgery: pragmatic solutions to improve cancer surgery outcomes worldwide. Tell us what you thought about this episode Continue this conversation on social! | |||
| Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma | 31 Oct 2023 | 00:17:10 | |
Doctor Philipp Karschnia (Ludwig-Maximilians-University of Munich, Munich, Germany) discusses the Response Assessment in Neuro Oncology consortium’s recommendations on standardised tissue sampling and processing during resection of diffuse intracranial glioma. Tell us what you thought about this episode Continue this conversation on social! | |||
| Wanda Cui on measuring ovarian toxicity | 03 Oct 2023 | 00:10:37 | |
Dr. Wanda Cui (Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia) discusses her Review on measuring ovarian toxicity in clinical trials. Tell us what you thought about this episode Continue this conversation on social! | |||
| Ticiana Leal on Tumour Treating Fields | 01 Sep 2023 | 00:09:01 | |
Ticiana Leal (Winship Cancer Institute at Emory University, Atlanta, GA, USA) discusses her paper on Tumour Treating Fields. Tell us what you thought about this episode Continue this conversation on social! | |||
| Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA | 02 Aug 2023 | 00:12:31 | |
Xuesong Han (American Cancer Society, Atlanta, GA, USA) discusses her study on changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA. Tell us what you thought about this episode Continue this conversation on social! | |||
| Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma | 03 Jul 2023 | 00:33:50 | |
Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma. Tell us what you thought about this episode Continue this conversation on social! | |||
| Madeline Pe on the SISAQOL initiative | 31 May 2023 | 00:14:01 | |
Madeline Pe (EORTC, Brussels, Belgium) discusses her Policy Review on the innovative medicines initiative, an expansion of the Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials (SISAQOL) initiative. Tell us what you thought about this episode Continue this conversation on social! | |||
| Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children | 02 May 2023 | 00:28:40 | |
Dr Kadia Petricca (SickKids Hospital, Toronto, Canada), Dr Joyce Kambugu (Uganda Cancer Institute, Kampala, Uganda), and Dr Avi Denburg (SickKids Hospital) discuss their paper “Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa”. Tell us what you thought about this episode Continue this conversation on social! | |||
| Mark Lythgoe on UK oncology drug approval after Brexit | 27 Mar 2023 | 00:14:11 | |
Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit". Tell us what you thought about this episode Continue this conversation on social! | |||
| Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations | 24 Jun 2024 | 00:36:56 | |
Dr Hisham Mehanna (University of Birmingham, Birmingham, UK) and Dr Sue Yom (University of California, San Francisco, San Francisco, CA, USA) discuss their four-paper Series on Head and Neck Cancer Consensus Recommendations in diagnosis and clinical trial endpoints. Tell us what you thought about this episode Continue this conversation on social! | |||
| Janet Brown on the phase 2/3 STAR trial | 28 Feb 2023 | 00:20:43 | |
Prof Janet Brown (University of Sheffield, Sheffield, UK) discusses the phase 2/3 STAR trial on treatment cessation versus continuation with tyrosine kinase inhibitors in advanced renal cell carcinoma. Tell us what you thought about this episode Continue this conversation on social! | |||
| Valerie Speirs on biomarkers in male breast cancer | 30 Jan 2023 | 00:17:40 | |
Prof Valerie Speirs (University of Aberdeen, Aberdeen, Scotland) discusses her Systematic Review on genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers in male breast cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| Sameer Bakhshi on sex disparities in childhood cancer in India | 03 Jan 2023 | 00:23:02 | |
Prof Sameer Bakhshi, (All India Institute of Medical Sciences, New Delhi, India) discusses his Article on sex disparities in childhood cancer in India. Tell us what you thought about this episode Continue this conversation on social! | |||
| Shankar Siva on radiotherapy for primary renal cell carcinoma | 28 Nov 2022 | 00:08:30 | |
Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma. Tell us what you thought about this episode Continue this conversation on social! | |||
| Mark Lawler and Richard Sullivan on the European Groundshot | 15 Nov 2022 | 00:23:20 | |
Mark Lawler (Queen’s University Belfast, Belfast, UK) and Richard Sullivan (Kings College London, London, UK) discuss the European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission. Tell us what you thought about this episode Continue this conversation on social! | |||
| Samar Alhomoud on challenges for cancer control in the Gulf region | 31 Oct 2022 | 00:11:27 | |
Samar Alhomoud (King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia) discusses her review on progress and remaining challenges for cancer control in the Gulf Cooperation Council. Tell us what you thought about this episode Continue this conversation on social! | |||
| Inge Marie Svane on mRNA vaccines for cancer treatment | 27 Sep 2022 | 00:08:11 | |
Inge Marie Svane (Copenhagen University Hospital, Copenhagen, Denmark) discusses her Review on clinical advances and ongoing trials on mRNA vaccines for cancer treatment. Tell us what you thought about this episode Continue this conversation on social! | |||
| Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer | 30 Aug 2022 | 00:11:39 | |
Eline Giraud and Elise Smolders from the (Radboud University Medical Center, Nijmegen, Netherlands) discuss their Review on QT interval prolongation potential of anticancer and supportive drugs. Tell us what you thought about this episode Continue this conversation on social! | |||
| Ignace Vergote and Maria Kyrgiou on gynaecological cancers | 25 Jul 2022 | 00:10:30 | |
Ignace Vergote (Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium) and Maria Kyrgiou (Imperial College London, London, UK) discuss their Series papers on gynaecological cancers. Tell us what you thought about this episode Continue this conversation on social! | |||
| David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer | 30 Jun 2022 | 00:05:19 | |
David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe. Tell us what you thought about this episode Continue this conversation on social! | |||
| Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment | 28 May 2024 | 00:24:08 | |
Dr Garth Strohbehn (Veteran Affairs Center for Clinical Management Research, Ann Arbor, Michigan, USA) and Dr Katie Lichter (University of California, San Francisco, USA) discuss their papers on the environmental impact of cancer treatments and the public harms resulting from it. Tell us what you thought about this episode Continue this conversation on social! | |||
| Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr on cancer in sub-Saharan Africa | 09 May 2022 | 00:30:55 | |
Wilfred Ngwa (Harvard Medical School, Boston, MA, USA; Johns Hopkins University, Baltimore, MD, USA; ICT University, Yaounde, Cameroon), Beatrice Wiafe-Addai (Peace and Love Hospital, Kumasi, Ghana), and David Kerr (University of Oxford, Oxford, UK) discuss the Lancet Oncology Commission on cancer in sub-Saharan Africa. Tell us what you thought about this episode Continue this conversation on social! | |||
| Georgios Lyratzopoulos on emergency presentation | 28 Apr 2022 | 00:13:44 | |
Georgios Lyratzopoulos (Institute of Epidemiology & Health Care at University College London, London, UK) discusses his population-based study on risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission. Tell us what you thought about this episode Continue this conversation on social! | |||
| Lisa Iezzoni on disabilities and cancer, and Jordan Marchak on mental health problems in young cancer survivors | 29 Mar 2022 | 00:12:53 | |
Lisa Iezzoni (Massachusetts General Hospital, Boston, MA, USA) discusses her Series paper on disabilities and cancer and Jordan Marchak (Children’s Healthcare of Atlanta, Atlanta, GA, USA) discusses her Review on surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors. Tell us what you thought about this episode Continue this conversation on social! | |||
| Rosie Bradley on early-stage breast cancer treatment | 28 Feb 2022 | 00:04:33 | |
Rosie Bradley (Oxford Population Health, University of Oxford, Oxford, UK) discusses her Article on aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression. Tell us what you thought about this episode Continue this conversation on social! | |||
| Yi-Long Wu and Caicun Zhou on non-small-cell lung cancer | 01 Feb 2022 | 00:09:56 | |
Prof Yi-Long Wu (Guangdong Lung Cancer Institute, Guangzhou, China) and Prof Caicun Zhou (Shanghai Pulmonary Hospital, Shanghai, China) discuss the GEMSTONE 301 and GEMSTONE 302 trials on sugemalimab versus placebo in non-small-cell lung cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| Rebecca Fitzgerald on Barrett's oesophagus surveillance | 31 Jan 2022 | 00:07:25 | |
Rebecca Fitzgerald (University of Cambridge, Cambridge, UK) discusses her Article on the use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance. Tell us what you thought about this episode Continue this conversation on social! | |||
| Elysia Alvarez on adolescent and young adult cancer | 29 Dec 2021 | 00:04:05 | |
Elysia Alvarez (UC Davis Comprehensive Cancer Center, Sacramento, USA) discusses her Article on the analysis of the global burden of adolescent and young adult cancer in 2019. Tell us what you thought about this episode Continue this conversation on social! | |||
| Aju Mathew on cancer care in India | 29 Nov 2021 | 00:06:08 | |
Aju Mathew (Malankara Orthodox Syrian Church Medical College and Hospital, Kerala, India) discusses his Review on financial toxicity in cancer care in India. Tell us what you thought about this episode Continue this conversation on social! | |||
| David Pinato on cancer patients who recovered from SARS-CoV-2 infection | 04 Nov 2021 | 00:08:33 | |
David Pinato (Imperial College London, Hammersmith Hospital, London, UK) discusses his Article on prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection. Tell us what you thought about this episode Continue this conversation on social! | |||
| James Glasbey on the effect of lockdowns on cancer surgery | 01 Nov 2021 | 00:07:12 | |
James Glasbey (UK NIHR Global Health Research Unit on Global Surgery, University of Birmingham, Birmingham, UK) discusses his Article on the effect of COVID-19 pandemic lockdowns on planned cancer surgery. Tell us what you thought about this episode Continue this conversation on social! | |||
| James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean | 29 Apr 2024 | 00:35:05 | |
Dr James Shultz, (University of Miami Miller School of Medicine, Miami, USA), Dr Ana Patricia Ortiz (University of Puerto Rico, and University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico), and Dr Leticia Nogueira (American Cancer Society, Georgia, USA) discuss their Personal View entitled, ‘Protecting Caribbean patients diagnosed with cancer from compounding disasters. Tell us what you thought about this episode Continue this conversation on social! | |||
| Manju Sengar and Christopher Booth on essential cancer drugs | 27 Sep 2021 | 00:11:55 | |
Manju Sengar (Tata Memorial Centre, India) and Christopher Booth (Queen’s University Cancer Research Institute, Canada) discuss their Article on the comparison between cancer drugs deemed essential by oncologists and those included in the WHO Essential Medicines List. Tell us what you thought about this episode Continue this conversation on social! | |||
| Susannah Stanway, Richard Cowan, Danielle Rodin, and Miriam Mutebi on helping with cancer control in LMICs | 31 Aug 2021 | 00:28:02 | |
Susannah Stanway (UK Global Cancer Network), Richard Cowan (Christie NHS Foundation Trust, UK), Danielle Rodin (Princess Margaret Cancer Centre, Canada), and Miriam Mutebi (Aga Khan University Hospital, Kenya) discuss the Global Cancer Control Networks Series on how high-income countries, particularly the UK and Canada, can help with cancer control in low-income and middle-income countries. Tell us what you thought about this episode Continue this conversation on social! | |||
| Harriet Rumgay on the burden of cancer attributable to alcohol | 30 Jul 2021 | 00:06:45 | |
Harriet Rumgay (International Agency for Research on Cancer, France) discusses the recent global burden of cancer in 2020 attributable to alcohol consumption study. Tell us what you thought about this episode Continue this conversation on social! | |||
| Rafael Cardoso and Hermann Brenner on colorectal cancer | 28 Jun 2021 | 00:06:41 | |
Rafael Cardoso and Hermann Brenner (German Cancer Research Center, Heidelberg, Germany) discuss their recent paper on colorectal cancer incidence, mortality, and stage distribution in Europe. Tell us what you thought about this episode Continue this conversation on social! | |||
| Takayuki Yoshino on the DESTINY-CRC01 trial | 01 Jun 2021 | 00:05:49 | |
Takayuki Yoshino (National Cancer Center Hospital East, Kashiwa, Japan) discusses the DESTINY-CRC01 trial on trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| Roberto Orecchia on the ELIOT trial | 28 Apr 2021 | 00:06:44 | |
Roberto Orecchia (European Institute of Oncology IRCCS) discusses the ELIOT trial on intraoperative irradiation for early breast cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| Hedvig Hricak, Andrew Scott, Rifat Atun, and May Abdel-Wahab on nuclear medicine | 31 Mar 2021 | 00:28:10 | |
Hedvig Hricak (Memorial Sloan Kettering Cancer Center), Andrew Scott (Olivia Newton-John Cancer Research Institute), Rifat Atun (Harvard TH Chan School of Public Health), and May Abdel-Wahab (International Atomic Energy Agency) discuss the latest Lancet Oncology’s Commission on Medical Imaging and Nuclear Medicine. Tell us what you thought about this episode Continue this conversation on social! | |||
| Ariana Znaor on breast and cervical cancer in the former Soviet Union | 01 Mar 2021 | 00:09:44 | |
Ariana Znaor, International Agency for Research on Cancer, discusses her Article on breast and cervical cancers stage distributions in ten newly independent states of the former Soviet Union. Tell us what you thought about this episode Continue this conversation on social! | |||
| Sathira Perera on global cancer surgery | 21 Jan 2021 | 00:07:47 | |
Sathira Perera (University of New South Wales, Australia) discusses his (and colleagues) Articles on the global use of cancer surgery. Tell us what you thought about this episode Continue this conversation on social! | |||
| Short-course radiotherapy for advanced rectal cancer | 04 Jan 2021 | 00:06:39 | |
Geke Hospers (University Medical Center Groningen, The Netherlands) discusses the RAPIDO trial Article published in The Lancet Oncology. Tell us what you thought about this episode Continue this conversation on social! | |||
| Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials | 08 Apr 2024 | 00:11:22 | |
Dr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| The crucial role of oncology nurses in cancer care | 16 Nov 2020 | 00:26:50 | |
Annie Young (University of Warwick, UK) and Julia Challinor (University of California San Francisco, USA) present their two-paper Series on Oncology Nursing. Tell us what you thought about this episode Continue this conversation on social! | |||
| The effect of climate change on cancer control | 02 Nov 2020 | 00:11:47 | |
Robert Hiatt (University of California San Francisco, USA) discusses his and Naomi Beyeler’s (same University) Review on climate change and cancer. Tell us what you thought about this episode Continue this conversation on social! | |||
| Maria Kyrgiou on innovations in gynaecological cancers and global disparities | 07 Mar 2024 | 00:25:42 | |
In a special episode on International Women's Day 2024, we speak with Dr Maria Kyrgiou (Imperial College London, London, UK) about her Essay on innovations and disparities in gynaecological cancer care. Tell us what you thought about this episode Continue this conversation on social! | |||
| Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers | 26 Feb 2024 | 00:34:43 | |
Dr Georgios Lyratzopoulos (University College London, London, UK) discusses his two papers from the International Cancer Benchmarking Partnership on the use of chemotherapy or radiotherapy in eight common cancers in Norway, the UK, Canada, and Australia. Tell us what you thought about this episode Continue this conversation on social! | |||